ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,188Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 1448

$531K Total Retail Price of All Prescriptions

Rank: 116 out of 1448

478 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

22% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 6,892 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 436 340 1 3
HYDROCODONE-ACETAMINOPHEN 378 193 S3 2 33
CARVEDILOL 371 278 3 1
FUROSEMIDE 305 233 4 7
LISINOPRIL 270 188 5 5
METFORMIN HCL 257 185 6 25
LEVOTHYROXINE SODIUM 244 179 7 21
METOPROLOL SUCCINATE 219 167 8 6
IBUPROFEN 202 119 9 85
OMEPRAZOLE 199 142 10 23
AMLODIPINE BESYLATE 183 128 11 2
LOSARTAN POTASSIUM 174 153 12 11
ZOLPIDEM TARTRATE 164 76 13 34
CITALOPRAM HBR 149 46 14 129
WARFARIN SODIUM 143 93 15 8
ATENOLOL 136 122 16 12
ALLOPURINOL 133 92 17 43
GABAPENTIN 131 82 18 51
CIPROFLOXACIN HCL 117 77 19 137
POTASSIUM CHLORIDE 116 77 20 19
CLONIDINE HCL 112 101 21 45
ATORVASTATIN CALCIUM 111 82 22 4
COREG CR 109 85 23 83
EVISTA 105 84 24 134
LOSARTAN-HYDROCHLOROTHIAZIDE 96 76 25 38
LOVAZA 95 75 26 39
RANITIDINE HCL 90 71 27 109
FLUTICASONE PROPIONATE 88 57 28 130
LOVASTATIN 87 61 29 35
GLIPIZIDE 85 67 30 75
PROAIR HFA 84 52 31 104
DIOVAN 83 83 32 15
TAMSULOSIN HCL 78 64 33 46
DIOVAN HCT 75 66 34 29
VESICARE 75 56 34 205
TRAMADOL HCL 71 20 36 56
FLUOXETINE HCL 69 33 37 164
GEMFIBROZIL 69 48 37 127
METOPROLOL TARTRATE 67 42 39 9
GLYBURIDE 66 33 R 40 89
JANUMET 62 36 41 119
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 33 41 151
DIGOXIN 61 46 43 13
GLIMEPIRIDE 60 34 44 66
ADVAIR DISKUS 59 51 45 74
CELEBREX 57 44 46 77
AZITHROMYCIN 57 44 46 76
PANTOPRAZOLE SODIUM 56 42 48 42
DICYCLOMINE HCL 55 24 49 248
AMIODARONE HCL 55 54 49 22
NAPROXEN 54 19 51 112
HYDROCHLOROTHIAZIDE 52 36 52 18
JANUVIA 51 51 53 64
SYNTHROID 51 38 53 90
BENAZEPRIL HCL 51 44 53 26
AMITRIPTYLINE HCL 50 26 R 56 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.